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Background: The purpose of the study was to examine the effect of a foot-worn biomechanical device on the
clinical measurements and gait patterns of patients with total hip arthroplasty (THA).
Methods: Nineteen patients, up to 3 months post-THA, were enrolled to the study. Patients underwent a
computerized gait analysis to calculate spatiotemporal parameters and completed the Western Ontario and
McMaster Universities osteoarthritis index and the SF-36 health survey. Patients then began therapy with a non-
invasive foot-worn biomechanical device coupled with a treatment methodology (AposTherapy). Patients received
exercise guidelines and used the device daily during their regular activities at their own environment. Follow-up
examinations were conducted after 4, 12, and 26 weeks of therapy. Repeated measures ANOVA was used to
evaluate changes over time. The clinical significance of the treatment effect was evaluated by computing the
Cohen's effect sizes (ES statistic).
Results: After 26 weeks of therapy, a significant improvement was seen in gait velocity (50.3%), involved step
length (22.9%), and involved single limb support (16.5%). Additionally, a significant reduction in pain (85.4%) and
improvement in function (81.1%) and quality of life (52.1%) were noted.
Conclusions: Patients following THA demonstrated a significant improvement in gait parameters and in self-
assessment evaluations of pain, function, and quality of life. We recommend further RCTs to examine the effect of
this therapy compared to other rehabilitation modalities following THA and compared to healthy matched controls.
Trial registration: Clinical trial registration number NCT01266382
Keywords: Biomechanical therapy, Gait, Pain, FunctionBackground
Total hip arthroplasty (THA) is known to be a success-
ful joint replacement procedure given that most patients
experience significant pain alleviation, as well as an im-
provement in their health-related quality of life mostly
during the first postoperative year and beyond [1,2]. The
literature reveals, however, that despite these postopera-
tive improvements, in some patients, the level of pain* Correspondence: researchdept10@gmail.com
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reproduction in any medium, provided the orand the quality of life following THA do not reach those
of the general population [1-3], nor does their gait
pattern return to normal [4-6].
Gait analysis is a useful tool in the evaluation of loco-
motor function after THA [7]. Several studies have
shown that joint motion does not return to normal after
6 months and in some cases up to years postoperatively
[4,5,8]. This atypical joint motion includes additional
stress being placed on the unaffected leg that may even-
tually lead to the development of osteoarthritis (OA) in
the contralateral limb [6,9-11] and other joint disorders,
some of which may even require a second arthroplastytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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following THA do reach normal values. A recent study
has examined the gait pattern outcome of two different
surgical techniques for THA and reported one technique
to be superior. Therefore, the surgical technique should
be considered when evaluating the gait patterns of
patients following THA. In addition, another study has
examined resurfacing of the hip compared to THA and
found similar results [13]. Both studies compared the
operated patients with healthy controls and reported
that the operated groups have reached the values of
healthy controls.
In comparison with healthy individuals, THA patients
generally exhibit a residual antalgic gait with slower gait
velocity, shorter single limb support, and lower hip ad-
duction and extension angles [14-18]. These deviations
from normal individuals may be due to pain-avoidance
strategies adopted preoperatively, apprehensions associ-
ated with the new prosthesis that leads to mechanical
changes in the contralateral hip, and muscle weakness
[4,5,14,15,19,20].
Gait adaptations to THA are also found at the non-
operated hip and lead to limb asymmetry (i.e., differ-
ences in gait parameters between the operated and the
non-operated limb) [21]. Patients with THA put less
weight on their affected limb and do so less rapidly than
with their unaffected limb [5,19,22-24].
A relatively new non-invasive foot-worn biomechanical
device (AposTherapy) has been shown to improve clinical
measures, as well as gait patterns and limb symmetry in
patients with knee OA and chronic non-specific low back
pain [25-29]. Specifically, this device was shown to reduce
pain and functional limitation in patients with knee OA
and to improve the quality of life of patients with knee OA.
This therapy was also shown to improve gait velocity, step
length, and single limb support of patients with knee OA
and low back pain. Finally, the therapy was shown to im-
prove kinematic and kinetic parameters of gait; mainly, it
has been shown to reduce knee adduction moment. This
therapy uses a device that has the capability of changing
the location of the center of pressure (COP) during walk-
ing, thereby shifting the external forces acting on the body
[30,31]. Furthermore, the device generates perturbation
during movement that challenges neuromuscular control
[32]. We presume that this therapy may have positive effect
for patients following THA due to end-stage hip OA. The
ability of the device to change the COP alongside con-
trolled perturbation while walking will help patients follow-
ing THA to comply with walking exercise and adopt new
motion patterns. As mentioned, patients following THA
present altered gait patterns compared to healthy controls,
even a year post-surgery. We think that using this therapy
will help return the gait patterns of these patients to be
similar to the gait patterns of healthy controls.The purpose of the current study was to conduct a
pilot investigation to examine the applicability of this de-
vice on gait patterns, gait symmetry, and self-assessment
levels of pain, function, and quality of life in patients fol-
lowing THA. We hypothesized that this therapy will lead
to reduction in pain and improvements in the function
and quality of life of these patients. We also hypothe-
sized that these patients will show improved gait pat-
terns and diminished limb asymmetry.Materials and methods
Patients
Nineteen patients (ten males and nine females) with uni-
lateral THA participated in this study. Their mean (SD)
age was 63 (9.8) years, height was 164.6 (7.4) cm, and
weight was 74.8 (15.9) kg. The inclusion criterion was a
THA due to idiopathic hip OA up to 3 months post-
surgery. Exclusion criteria were (a) previous THA in the
contralateral hip, (b) other joint replacement procedures
in the lower limbs, (c) pain or limitation in other lower
extremity joints, (d) neurological and rheumatic inflam-
matory diseases, (e) postoperative dislocation or infection,
(f) postoperative deep vein thrombosis, (g) malpositioning
of the implant (abduction angle of the cup of 45° ± 10°),
and (h) intraoperative periprosthesis fracture. All pa-
tients were implanted with cementless prostheses with
ceramic on ceramic bearings (Corail and pinnacle cap,
J&J, DePuy, Warsaw, IN, USA). All patients were oper-
ated with the same surgical technique. The surgical ap-
proach was modified in a translateral approach with
splitting of the gluteus medius and minimus, opening
the capsule and anterior dislocation of the hip joint.
After reduction of the prosthesis components, the cap-
sule was sutured as well as the gluteus medius and
then the tensor fascia lata. In all patients, a subcutane-
ous drainage was used for the first 24 h. All patients
were radiographically assessed immediately at the end
of the operative procedure as well as 3 months post-
surgery.
Informed written consent, approved by the Assaf
Harofeh Medical Center ethic committee, was obtained
from all patients prior to their involvement in the
study (submission number 93/09, clinical trial registra-
tion number NCT01266382).
Patients were referred to the therapy center by a group
of orthopedic surgeons between February 2009 and
March 2010. All referred patients began therapy; how-
ever, some patients who were advised to begin this ther-
apy declined to participate due to personal reasons
(time-consuming, distance, did not want to commit). All
patients underwent the traditional rehabilitation proto-
col as advised to them by their orthopedic surgeon prior
to their arrival to the therapy center.
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The biomechanical system (Apos System, Apos–Sports
and Medical Technologies Ltd., Herzliya, Israel) is a
device combined with a treatment methodology. The
device consists of four convex-shaped biomechanical
elements with two attached to each of the patient's feet
(Figure 1). One is located under the hindfoot region, and
the other is located under the forefoot region. The ele-
ments are attached to the patient's foot using a platform
in the form of a shoe. The platform is equipped with a
specially designed sole that consists of two mounting
rails that enable flexible positioning of each element
under each region. The device is calibrated to the indi-
vidual patient according to his or her pathology and mo-
tion characteristics. Each patient is asked to walk away
from and then back towards the therapist. A visual gait
evaluation is carried out by the therapist, and the device
is appropriately calibrated. Appropriate calibration is de-
fined as bringing the damaged joint to a biomechanical
alignment that minimizes/eliminates pain. This is done
by changing the location of the biomechanical elements,
which changes the COP and shifts and changes the
applied forces acting on the joints [30,31]. Together with
biomechanical perturbations, this device enables home-
based, dynamic, functional, and repetitive training intended
to improve neuromuscular control. Following first assess-
ment and calibration of the biomechanical device, each
patient receives an exercise guideline according to a treat-
ment protocol for each indication. In the current study, pa-
tients were instructed to follow a treatment protocol based
on walking during activities of daily living, starting with 10
min of indoor walking each day during the first week andFigure 1 Apos System. (A) Biomechanical device comprising of two indiv
are attached under the hindfoot and forefoot regions of the platform. (B) T
convexity and resilience. (C) The specially designed sole of the platform inc
positioning of each biomechanical element.gradually increasing to 30 min of daily outdoor walking
after 12 weeks.
Questionnaires
All patients completed three questionnaires: (a) visual
analog scale (VAS) for the operated hip and the non-
operated hip, (b) the Western Ontario and McMaster
Universities osteoarthritis index (WOMAC) [33], and (c)
the Short Form Health Survey (SF-36) [34]. In addition,
the therapist completed the Harris hip score (HHS) [35].
The average (SD) VAS score at baseline for the oper-
ated hip and for the non-operated hip was 28.4 (26.6)
and 5.9 (11.9), respectively. The average (SD) WOMAC
score of pain, stiffness, and function results at baseline
were 17.1 (22.2), 20.6 (18.5), and 32.5 (19.1), respectively.
The average (SD) score for the SF-36 physical scale and
for the SF-36 mental scale at baseline were 49.3 (21.3)
and 59.1 (21.6), respectively.
Functional test
A timed up and go [36] (TUG) functional test was car-
ried out. A standard height chair was used, and a line
was placed 3 m from the chair. Each patient was asked
to repeat the test three times, and the average of the
three trials was calculated for further analysis.
Gait analysis
The GaitMat system (E.Q. Inc., Chalfont, PA, USA) was
used to measure spatiotemporal parameters [37]. During
the gait test, all patients walked barefoot at a self-
selected speed. Patients walked 3 m before and after the
walkway mat (approximately 4 m in length) to allowidually calibrated elements and a foot-worn platform. The elements
he biomechanical elements are available in different degrees of
ludes two mounting rails and a positioning matrix to enable flexible
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measurement area. Each gait test included four walks,
and the mean value of the four walks was calculated for
each parameter. Measured variables included: velocity
(centimeter per second), step length (centimeter), and
single limb support (SLS) (percent gait cycle, GC). SLS
is a phase in the GC in which the body weight is entirely
supported by one limb while the contralateral limb
swings forward. Temporal distance (T-D) symmetry was
calculated for SLS and step length using the formula:
involved uninvolved
involvedþ uninvolvedð Þ=2 100
A symmetry index value of zero represents perfect
symmetry. A positive value indicates that the magnitude
of that variable was larger in the involved limb, and a
negative value denotes a larger magnitude in the unin-
volved limb [38]. A 5% difference between limbs was
considered to be a normal value.
Protocol
All measured variables were evaluated during the first visit,
after which the biomechanical device was individually cali-
brated. Treatment was then initiated and continued daily
for a period of 6 months. Follow-up examinations were
carried out after 4-, 12-, and at the 26-week end point. The
physiotherapist verified compliance to the treatment proto-
col during each of the follow-up examinations.
Statistical analysis
The goal of the proposed pilot study, which is one arm
prospective study, was to test the hypothesis that there
are significant improvements over time in pain, function,
and SF scales. As this is a pre-experimental study, we
could not determine the study sample size in advance.
The criterion for significance (alpha) has been set at
0.050. The test is two-tailed, which means that an effect
in either direction will be interpreted. With the pro-
posed sample size of 19 patients and 19 for the two
groups, the study will have a power of at least 80% to
yield a statistically significant result. This computation
assumes that the mean difference is 14.0 (corresponding
to means of 17.0 versus 3.0), and the common within-
group standard deviation is 14.3 (based on SD estimates
of 20.0 and 3.0).
Data were analyzed with SPSS software version 19.0.
(SPSS Inc., Chicago, IL, USA). The significance levels
were set at 0.05.
The distributions of gait characteristics were examined
using the Kolmogorov–Smirnov non-parametric test.
Data were presented as mean and standard deviation for
continuous variables following with 95% confidence in-
tervals for the mean.Changes over time for all measurements were calcu-
lated by the repeated measures ANOVA. The clinical
significance of the treatment effect was evaluated by
computing the Cohen's effect sizes (ES statistic, differ-
ence between two time points divided by the standard
deviation at baseline) on gait velocity, step length, pain,
and function and were compared to previous findings by
other researchers.
Results
None of the patients had postoperative complications in-
cluding dislocation or infection as well as deep vein
thrombosis. In addition, none of the patients had radio-
lucencies or suspected osteolysis. All patients complied
with the treatment protocol. Compliance was verified at
several points during the study. Patients received a tele-
phone call to verify compliance at the 1st, 2nd, 10th,
16th, and 20th week of treatment. There were no reports
of imbalance, tripping, or any other adverse events dur-
ing the study period.
All gait parameters (velocity, step length, and single
limb support) improved significantly (P value ranged be-
tween 0.04 and <0.001) except for the uninvolved SLS.
Significant improvements were found between all time
points (4, 12, and 26 weeks), each time point compared
to baseline, in all measurements except for the unin-
volved step length at the 6-month time point (Figure 2).
Step length symmetry and SLS symmetry significantly
changed over time, each time point compared to base-
line (P < 0.001). At baseline, there was a 17.4% asym-
metry in step length and a −98.2% asymmetry in SLS.
Step length asymmetry was 2.5%, 1.1%, and 10% after 4,
12, and 26 weeks of treatment, respectively. SLS asym-
metry was −11.9%, −6.9%, and −6.8% after 4, 12, and 26
weeks of treatment, respectively. Alongside the improve-
ment in gait measurements, a significant improvement
was also seen in the TUG functional test between all
time points, P < 0.001. Mean TUG (SD) was 12.6 (4.0) s,
8.1 (3.1) s, 7.6 (3.2) s, and 6.9 (2.7) s at baseline, 4, 12,
and 26 weeks, respectively, (each time point compared
to baseline). Overall, there was a mean improvement of
42% in the TUG test compared to the baseline result.
Patients reported a significant decrease in their level of
pain (P value ranged between 0.05 and <0.001) and stiff-
ness (P value ranged between 0.05 and <0.001) and a
significant improvement in their level of function (P value
ranged between 0.002 and <0.001) at all time points com-
pared to their baseline results. Patients also reported a sig-
nificant improvement in the SF-36 physical scale (P value
ranged between 0.003 and <0.001) and mental scale (P
value ranged between 0.002 and <0.001) compared to
their baseline results (Table 1). When comparing the level
of pain between the operated limb and the non-operated
limb, based on the separated VAS scale for each limb, it
Figure 2 Changes in gait velocity, step length, and single limb
support following 6 months of AposTherapy. A significant
improvement was seen in all gait variables. All P values were <0.05.
SLS, single limb support; GC, gait cycle.
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significantly reduced following the treatment whereas the
level of pain in the non-operated limb did not change sig-
nificantly over time (Table 2). The results of the HHS are
summarized in Table 2. A significant increase was seen
between all time points compared to their baseline results.
Discussion
To date, there is insufficient evidence regarding the
effectiveness of rehabilitation modalities for patients fol-
lowing THA. It is known that the level of pain and the
quality of life of these patients following THA do not
reach those of the general population [1-3], nor does
their gait pattern return to normal [4-6]. The presentstudy was a pilot investigation to examine the applicabil-
ity of this device on gait patterns, gait symmetry, and
self-assessment levels of pain, function, and quality of
life in patients following THA. It was found that gait
patterns, including gait symmetry, significantly improved
over time. Furthermore, a significant improvement was
also found in the TUG functional test. Patients also
reported a significant reduction in pain and improve-
ment in function and quality of life.
The gait characteristics of patients from the current
study were compared with normal gait values drawn
from the literature. Patients from the current study had
reached normal SLS values after 12 weeks of treatment.
This finding indicates that patients were able to bear the
entire body weight on both the operated hip and non-
operated hip. Results regarding gait velocity, however,
are controversial. Compared to some studies, patients
from the current study did not reach normal gait vel-
ocity values, whereas compared to other studies, they
did [7,39,40]. Based on the finding of Kyriazis and Rigas
that characterized the spatiotemporal parameters of pa-
tients following THA, patients from the current study
have equaled their gait velocity value with the gait vel-
ocity value of the general population. Patients with
THA from the general population reached this value
after 8–10 years post-surgery [7], whereas patients in the
current study have reached this value after 6 months.
An important finding of this study was the improve-
ment in limb symmetry. Shakoor et al. suggested that
patients with unilateral THA for end-stage OA are at
high risk for future progression of OA in other joints of
the lower extremities, often requiring additional joint re-
placements [12]. This is probably because of prolonged
abnormal gait adaptations over the years prior to surgery
and can also be a result of gait alterations in response to
pain or fear following surgery [41]. In response to sur-
gery, patients may unload the operated limb and over-
load the contralateral limb. Symmetry will be achieved
over time; however, it will be on the expense of the
healthy limb. For example, following a THA, the reduc-
tion in loads in the operated limb will reduce the SLS of
the limb while the increase in loads in the contralateral
limb will increase the SLS of the limb, even to values
above the normal. As the body aspires to symmetry, the
patient will reduce his or her SLS values in the healthy
limb towards the values in the operated limb. In the
current study, patients reached step length symmetry
after 4 weeks and SLS symmetry after 12 weeks of treat-
ment. Symmetry was achieved through an increase in
step length in the contralateral limb and an increase in
SLS in the operated limb, both reaching normal values.
Patients in the current study reported a significant re-
duction in pain and stiffness and an improvement in
function and quality of life. The effect of rehabilitation
Table 1 WOMAC index and SF-36 Health Survey scores following 6 months of treatment
Baseline 4 weeks 12 weeks 26 weeks



















Pain 17.1 (22.2) 6.1 28.1 7.9 (12.2) 1.8 13.9 5.1 (8.0) 1.1 9.1 2.5 (2.9) 1.0 3.9 P = 0.007
Stiffness 20.6 (18.5) 11.4 29.9 12.6 (16.4) 4.4 20.7 8.0 (14.9) 0.6 15.4 3.9 (6.7) 0.5 7.2 P = 0.006
Function 32.5 (19.1) 23.0 42.0 13.4 (15.0) 6.0 20.9 10.9 (14.7) 3.6 18.2 7.8 (11.4) 2.1 13.4 P < 0.001
SF-36 Health
Survey (0–100)
Physical scale 49.3 (21.3) 39.0 59.5 59.9 (22.3) 49.2 70.7 69.6 (19.0) 60.4 78.7 75.0 (16.6) 67.0 83.1 P < 0.001
Mental scale 59.1 (21.6) 48.7 69.6 71.1 (18.5) 62.2 80.0 81.4 (12.6) 75.3 87.4 83.2 (15.3) 75.8 90.5 P < 0.001
aP value was set to P < 0.05. Results are presented as mean (SD) and 95% confidence interval (CI).
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function is not clear. Some studies did not find signifi-
cant differences between physiotherapy rehabilitation
and the control group, while others present some evi-
dence indicating a treatment benefit within a treatment
group compared to control [42,43].
Since this study did not have a control group, the re-
sults were compared to the results of other treatment
modalities that have been previously reported. A recent
comprehensive review examined the effectiveness of
physiotherapy exercise following THA. It was concluded
that there is insufficient evidence to establish the effect-
iveness of physiotherapy following THA for OA [42].
We further searched the literature to compare the re-
sults of the current study with previous reports. Table 3
summarizes the papers that were included in this com-
parison [44-47]. A calculation of the effect size (differ-
ence between two time points divided by the standard
deviation at baseline) was carried out on the parametersTable 2 VAS and Hariss hip form scores following 6 months o
Baseline 4 weeks
















5.9 (11.9) 0 11.8 1.7 (4.0) 0 3.7
Harris hip
form
63.8 (18.1) 55.1 72.6 80.8 73.6 88.0
aP value was set to P < 0.05. Results are presented as mean (SD) and 95% confidengait velocity, step length, pain, and function. The effect
size of AposTherapy on gait velocity was similar to the
effect of treadmill training and conventional physiother-
apy and was higher than all other treatment modalities
including low-intensity training, high-intensity training,
home-based exercise, and center-based exercise. The ef-
fect size of AposTherapy on the involved step length
was substantially higher than all other treatment modal-
ities. Similarly, the effect size of the therapy on the levels
of pain and function was substantially higher compared
to other treatment modalities.
This study had some limitations. First, this study did
not have a control group. Although the results of this
study were compared to previously reported findings of
studies that have examined the effect of other treatment
modalities, it would have been preferable to use a con-
trol group. Secondly, this study had a relatively small
number of patients. Another limitation to this study is a
lack of information regarding the patient's gaitf treatment
12 weeks 26 weeks









6.2 (1.2) 0.3 12.2 1.4 (0.4) 0 3.2 P = 0.002
2.1 (5.7) 0 4.9 4.3 (10.3) 0 9.4 P = 0.21
84.6 (13.2) 78.3 91.0 88.3 (11.9) 82.6 94.1 P < 0.001
ce interval (CI).















Home-based exercise (n = 12) 66.6 (7.9) 81.6 (20.3) 160 (10)
Husby et al. [45] 1 week 24 4 weeks Strength training (n = 12) 58 (5) 84.6 (11.2) 174 (9) Step length
Conventional rehabilitation (n = 12) 56 (8) 80.9 (18.4) 170 (11)
Jan et al. [46] 6 years 53 12 weeks High-intensity training (n = 13) 58.8 (12.9) Missing 159.5 (7.6) Gait velocity
Low-intensity training (n = 13) 59.3 (10.3) 158.4 (4.6)
Control (n = 27) 57.0 (12.8) 163.0 (9.7)
Hesse et al. [47] 3 weeks 79 10 days Treadmill therapy (n = 39) 64.7 (13.1) 70.9 (14.4) 166.4 (8.9) Harris hip score,
velocity
Control (n = 40) 65.5 (9.9) 72.7 (12.1) 166.6 (8.6)
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surgery. This information could have helped characterize
the study population. In addition, this study included pa-
tients 3 months post-surgery with relatively low values
of pain and functional disability but with compromised
gait characteristics. Information regarding patients' pain
and function level prior surgery and immediately after
surgery would have helped in further understanding the
study population. We recommend that future studies
examine the effect of AposTherapy in patients with
THA in a randomized controlled clinical trial.Conclusions
This study was a pilot investigation to examine the
applicability of this device on gait and clinical measure-
ments of patients following THA. The results of this
study showed promising outcomes including significant
improvements in gait patterns, functional tests, and self-
evaluation questionnaires; however, future RCT's are
warranted. These RCT's should include a comparison of
this therapy modality to other common modalities and
also compare this therapy with a group of healthy con-
trols. This will help determine and relate the improve-
ment to the therapy.Competing interests
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